Lv1
8 积分 2024-09-19 加入
Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review
4小时前
已完结
Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab
3个月前
已完结
Milvexian a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation
4个月前
已完结
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
5个月前
已完结
Systematic analysis of levels of evidence supporting Chinese clinical practice guidelines for gastrointestinal disease
5个月前
已完结
皖公网安备34019202002308
